PDS Biotech Announces Updated Results from VERSATILE-002 Phase 2 Clinical Trial Presented at ESMO 2024
September 16, 2024 07:00 ET
|
PDS Biotechnology Corporation
Median Overall Survival remains at 30 months; Objective Response Rate of 36% and Disease Control Rate of 77% 11/53 (21%) of patients experienced 90-100% tumor shrinkage VERSATILE-003 Phase 3...
Precision Drilling Announces Renewal of Normal Course Issuer Bid
September 13, 2024 06:00 ET
|
Precision Drilling Corporation
CALGARY, Alberta, Sept. 13, 2024 (GLOBE NEWSWIRE) -- This news release contains "forward-looking information and statements" within the meaning of applicable securities laws. For a full disclosure...
PDS Biotech to Present Updated VERSATILE-002 Data at ESMO Congress 2024
September 09, 2024 08:00 ET
|
PDS Biotechnology Corporation
PRINCETON, N.J., Sept. 09, 2024 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the...
United States Sleep Disorders Treatment Market 2024-2028, with Profiles of Better Night, Koala Centers, Marshall Medical Centers, Novasom, ResMed, Respironics, Sleep Holdings, SleepMed and More
September 04, 2024 09:08 ET
|
Research and Markets
Dublin, Sept. 04, 2024 (GLOBE NEWSWIRE) -- The "U.S. Sleep Disorders Treatment Market: Sleep Centers, Sleep Studies & CPAPs" report from Marketdata LLC has been added to ...
PDS Biotech to Present at H.C. Wainwright 26th Annual Global Investment Conference
September 03, 2024 08:00 ET
|
PDS Biotechnology Corporation
PRINCETON, N.J., Sept. 03, 2024 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the...
OSB GROUP PLC - Interim Report
August 15, 2024 02:00 ET
|
OSB GROUP PLC
LEI: 213800ZBKL9BHSL2K459 15 August 2024 THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION OSB GROUP PLCInterim report for the six months ended 30 June 2024 OSB GROUP PLC (OSBG or the Group), the...
PDS Biotech Provides Business Update and Reports Second Quarter 2024 Financial Results
August 13, 2024 08:00 ET
|
PDS Biotechnology Corporation
PRINCETON, N.J., Aug. 13, 2024 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the...
Bentonite Market Projected to Rise at a 6.2% CAGR, Reaching USD 2,827.4 Million by 2034 | Future Market Insights, Inc.
August 12, 2024 05:30 ET
|
Future Market Insights Global and Consulting Pvt. Ltd.
NEWARK, Del, Aug. 12, 2024 (GLOBE NEWSWIRE) -- The global bentonite market is anticipated to witness significant growth in the coming years, with its market size projected to reach approximately USD...
PDS Biotech Announces Abstract Accepted for Oral Presentation at 2024 ASTRO Annual Meeting
August 08, 2024 08:00 ET
|
PDS Biotechnology Corporation
PRINCETON, N.J., Aug. 08, 2024 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the...
Aveanna Healthcare Holdings Announces Second Quarter 2024 Financial Results and Revised 2024 Outlook
August 08, 2024 06:30 ET
|
Aveanna Healthcare Holdings, Inc
Second Quarter Revenue was $505.0 million, a 7.0% increase over the prior year Gross margin increased 1.9% to $158.3 million, compared to Q2 2023 Second Quarter Net income was $13.9 million,...